MATTER NO. 2026-041
M&A Indemnity
Delaware & London
2026
Meridian Biologics — Cross-Border Acquisition & Escrow Defense
Structured post-closing indemnity ring-fencing and defeated an $84M working-capital adjustment claim prior to Chancery filing.
$420M
Deal consideration advised
62% → 15%
Liability cap negotiated
Claire Aldridge · Managing Partner
LEAD COUNSEL PARTNER

RECORD METADATA
MATTER NO. 2026-041
Delaware & London
Claire Aldridge · Managing Partner
Mandate & Posture
Acting as lead seller counsel in a dual-track European and Delaware share purchase, Aldridge & Vance was retained ten days before scheduled execution when buyer drafts introduced uncapped fundamental survival alongside first-dollar recovery on working-capital adjustments.
Redline Strategy & Resolution
We re-anchored survival to a single eighteen-month statutory audit cycle, instituted a 0.75% tipping basket, and separated accounting objections into expedited expert determination rather than general breach indemnity.
Post-closing challenges totaling $84M were resolved within six weeks inside the agreed escrow structure with zero balance-sheet impairment to selling shareholders.